Compare SGMO & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SGMO | MGYR |
|---|---|---|
| Founded | 1995 | 1922 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.2M | 114.1M |
| IPO Year | 2000 | 2021 |
| Metric | SGMO | MGYR |
|---|---|---|
| Price | $0.13 | $17.40 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 9.1M | 2.5K |
| Earning Date | 05-07-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.30% |
| EPS Growth | 10.20 | ★ 26.83 |
| EPS | N/A | ★ 0.50 |
| Revenue | ★ $36,567,000.00 | N/A |
| Revenue This Year | $107.15 | N/A |
| Revenue Next Year | $76.44 | N/A |
| P/E Ratio | ★ N/A | $35.28 |
| Revenue Growth | ★ 88.60 | N/A |
| 52 Week Low | $0.12 | $14.10 |
| 52 Week High | $0.77 | $20.00 |
| Indicator | SGMO | MGYR |
|---|---|---|
| Relative Strength Index (RSI) | 25.62 | 47.35 |
| Support Level | N/A | $17.04 |
| Resistance Level | $0.55 | $17.93 |
| Average True Range (ATR) | 0.03 | 0.21 |
| MACD | -0.01 | -0.02 |
| Stochastic Oscillator | 8.19 | 23.08 |
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.